PantelK., Alix-PanabièresC. Circulating tumour cells in cancer patients: challenges and perspectives. Trends in Molecular Medicine, 16:398–406. (2010).
2.
JiangS., LiuY., XuY., et al.Research on liquid biopsy for cancer: A bibliometric analysis. Heliyon, 9(3):e14145. (2023).
3.
AshworthT. R. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. The Australasian Medical Journal. 14:146–149 (1869).
4.
HouJ., LiuX., ZhouS. Programmable materials for efficient CTCs isolation: from micro/nanotechnology to biomimicry. View, 2(6):20200023. (2021).
5.
PoellmannM.J., BuJ., LiuS., et al.Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients. Biosensors and Bioelectronics, 226L115117. (2023).
6.
WuN.J.W., AquilinaM., QianB-Z., et al.The application of nanotechnology for quantification of circulating tumour DNA in liquid biopsies: a systematic review. IEEE Reviews in Biomedical Engineering, 16:499–513. (2023).
7.
Martin-AlonsoC., TabriziS., XiongK., et al.A nanoparticle priming agent reduces cellular uptake of cell-free DNA and enhances the sensitivity of liquid biopsies. bioRxiv. (2023). https://doi.org/10.1101/2023.01.13.524003
8.
RakJ., StrzadalL. Heterogeneity of extracellular vesicles and particles: molecular voxels in the blood borne “hologram” of organ function, disfunction and cancer. Archivum Immunologiae et Therapiae Experimentalis, 72(1):5. (2023).
9.
JalaliM., MataC.d.R., MonterminiL., et al. MoS2-Plasmonic Nanocavities for Raman Spectra of Single Extracellular Vesicles Reveal Molecular Progression in Glioblastoma. ACS Nano, 17(13):12052–12071. (2023).
10.
WangJ., SunN., LeeY-T., et al.Prostate cancer extracellular vesicle digital scoring assay—a rapid noninvasive approach for quantification of disease-relevant mRNAs. Nanotoday. 48:101746. (2023).
11.
SinghS., MiglioneA., RaucciA., et al.Towards sense and sensitivity-based electrochemical biosensors for liquid biopsy-based breast cancer detection. TrACTrends in Analytical Chemistry, 163: 117050. (2023).
12.
SinghS., PodderP. S., RussoM., et al.Tailored point-of-care biosensors for liquid biopsy in the field of oncology. Lab on a Chip, 23(1):44–61. (2023).
13.
PremachandranS., HaldavnekarR., DasS., et al.DEEP surveillance of brain cancer using self-functionalized 3D nanoprobes for noninvasive liquid biopsy. ACS Nano, 16(11):17948–17964. (2022).
DoebleyA-L., KoM., LiaoH., et al.A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA. Nature Communication, 13:7475. (2022).
